Home/Recalls/AU-c520c3d8-2091-483d-99ee-4bca518e8b23
Australia ProductsPharmacy and me...

Philips Respironics - Certain CPAP and Bi-Level PAP Devices

Published: July 27, 2021Recall ID: c520c3d8-2091-483d-99ee-4bca518e8b23Category: generalCountry: Australia

Reason for Recall / Hazard

The polyester-based polyurethane (PE-PUR) sound abatement foam used in Philips Continuous and Non-Continuous Ventilators may: 1. Degrade into particles which may enter the device's air pathway and be ingested or inhaled by the user. The foam degradation may be exacerbated by use of unapproved cleaning methods, such as ozone; and 2. Emit certain chemicals (volatile organic compounds or VOCs).

Product Description & Identification

Reason / Defects: The polyester-based polyurethane (PE-PUR) sound abatement foam used in Philips Continuous and Non-Continuous Ventilators may: 1. Degrade into particles which may enter the device's air pathway and be ingested or inhaled by the user. The foam degradation may be exacerbated by use of unapproved cleaning methods, such as ozone; and 2. Emit certain chemicals (volatile organic compounds or VOCs). Hazards: Foam degradation: The potential risks of particulate exposure include: irritation (skin, eye, and respiratory tract), inflammatory response, headache, asthma, adverse effects to other organs (e.g. kidneys and liver) and toxic carcinogenic effects. VOC emission: The potential risks of chemical exposure due to off-gassing include: headache/dizziness, irritation (eyes, nose, respiratory tract, skin), hypersensitivity, nausea/vomiting, toxic and carcinogenic effects. What to do: It is important that you register your device as soon as possible at the support website www.philips.com/src-update Do not stop or alter your prescribed therapy; stopping treatment suddenly could have an immediate and detrimental effect on your health. Before making any changes to prescribed therapy, make an appointment with your physician or care provider to discuss alternative long term therapy options. Philips will write to affected consumers. Users and carers should review the information provided in the customer letter about the ongoing use of impacted devices. Philips will repair or replace the affected devices. For more information see the TGA safety alert at https://www.tga.gov.au/alert/philips-recall-action-cpap-bi-level-pap-devices-and-mechanical-ventilators For further information, please contact the Philips Support Hotline on 1800 009 579.

Affected Products

Philips Respironics - Certain CPAP and Bi-Level PAP Devices E30 (Emergency Use Authorization) DreamStation ASV DreamStation ST, AVAPS SystemOne ASV4 C-Series ASV C-Series S/T and AVAPS OmniLab Advanced+ SystemOne (Q-Series) DreamStation DreamStation Go Multiple Product Codes (See attached Product code list) All devices manufactured before 26 April 2021 ARTGs: 133792, 209934, 235674, 257012, 257013, 295664, 285420, 327227, 335508

Additional Source Details

FieldValue
Guid › #textc520c3d8-2091-483d-99ee-4bca518e8b23
Guid › @ is Perma Linkfalse
Linkhttps://www.productsafety.gov.au/search-consumer-product-recalls/philips-respironics-certain-cpap-and-bi-level-pap-devices
Pub DateTue, 27 Jul 2021 00:00:00 +0000
Extracted imagehttps://www.productsafety.gov.au/system/files/styles/large/private/Philips%20CPAP%20and%20BiLevel%20PAP%20Devices.jpg?itok=hTe13qWO

Overview

  • Risk LevelPharmacy and medical products
  • DistributionAustralia
Official Agency Alert